中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
7期
491-496
,共6页
邵志红%王培军%李铭华%张炜%郑少强%赵小虎%王国良%尚鸣异%毛新清
邵誌紅%王培軍%李銘華%張煒%鄭少彊%趙小虎%王國良%尚鳴異%毛新清
소지홍%왕배군%리명화%장위%정소강%조소호%왕국량%상명이%모신청
干细胞%磁共振成像%肝肿瘤
榦細胞%磁共振成像%肝腫瘤
간세포%자공진성상%간종류
Stem cells%Magnetic resonance imaging%Liver neoplasms
目的 评价大鼠骨髓间充质干细胞(MSC)移植对Walker-256肝癌生长的影响.方法 从大鼠腹水瘤株中提出并培养Walker-256细胞,采用商接肝内注射法制备大鼠肝癌模型.实验分2个实验组(MSC与肿瘤细胞混合移植组、MSC静脉移植组)和一个对照组,每组15只.所有实验动物均在术后第3、6、9、12天进行MR成像并测量肿瘤横断位最大层面而积的变化,第12天成像后取病理进行常规HE染色以及血管内皮细胞生长因子(VEGF)、nm23、增殖细胞核抗原(PCNA)、末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)法免疫组化分析.结果 MRI显示所有实验动物在术后第3、6天均末见明显肿瘤形成,第9天可见肿瘤结节生长,两个实验组肿瘤在第9、12天横断位最大层面面积均大于对照组(F=4.21,P<0.05;F=8.52,P<0.01).免疫组化结果 表明两个实验组肿瘤VEGF表达均明显高于对照组(F=9.58,P<0.01),nm23基因蛋白表达均低于对照组(F=4.61,P<0.05),MSC混合移植组PCNA表达高于对照组[d'(1,0.05)>=0.34,d'(1,0.01)>=0.63,P<0.05],MSC静脉移植组PCNA表达与对照组差异无统计学意义[d'(1,0.05)>=0.32,d'(1,0.01)>=0.48,P>0.05],2个实验组肿瘤凋亡指数与对照组差异均无统计学意义(F=1.25,P>0.05).结论大鼠MSC移植能影响Walker-256肝癌VEGF、nm23以及PCNA的表达,有利于肿瘤的生长.
目的 評價大鼠骨髓間充質榦細胞(MSC)移植對Walker-256肝癌生長的影響.方法 從大鼠腹水瘤株中提齣併培養Walker-256細胞,採用商接肝內註射法製備大鼠肝癌模型.實驗分2箇實驗組(MSC與腫瘤細胞混閤移植組、MSC靜脈移植組)和一箇對照組,每組15隻.所有實驗動物均在術後第3、6、9、12天進行MR成像併測量腫瘤橫斷位最大層麵而積的變化,第12天成像後取病理進行常規HE染色以及血管內皮細胞生長因子(VEGF)、nm23、增殖細胞覈抗原(PCNA)、末耑脫氧覈苷痠轉移酶介導的dUTP缺口末耑標記(TUNEL)法免疫組化分析.結果 MRI顯示所有實驗動物在術後第3、6天均末見明顯腫瘤形成,第9天可見腫瘤結節生長,兩箇實驗組腫瘤在第9、12天橫斷位最大層麵麵積均大于對照組(F=4.21,P<0.05;F=8.52,P<0.01).免疫組化結果 錶明兩箇實驗組腫瘤VEGF錶達均明顯高于對照組(F=9.58,P<0.01),nm23基因蛋白錶達均低于對照組(F=4.61,P<0.05),MSC混閤移植組PCNA錶達高于對照組[d'(1,0.05)>=0.34,d'(1,0.01)>=0.63,P<0.05],MSC靜脈移植組PCNA錶達與對照組差異無統計學意義[d'(1,0.05)>=0.32,d'(1,0.01)>=0.48,P>0.05],2箇實驗組腫瘤凋亡指數與對照組差異均無統計學意義(F=1.25,P>0.05).結論大鼠MSC移植能影響Walker-256肝癌VEGF、nm23以及PCNA的錶達,有利于腫瘤的生長.
목적 평개대서골수간충질간세포(MSC)이식대Walker-256간암생장적영향.방법 종대서복수류주중제출병배양Walker-256세포,채용상접간내주사법제비대서간암모형.실험분2개실험조(MSC여종류세포혼합이식조、MSC정맥이식조)화일개대조조,매조15지.소유실험동물균재술후제3、6、9、12천진행MR성상병측량종류횡단위최대층면이적적변화,제12천성상후취병리진행상규HE염색이급혈관내피세포생장인자(VEGF)、nm23、증식세포핵항원(PCNA)、말단탈양핵감산전이매개도적dUTP결구말단표기(TUNEL)법면역조화분석.결과 MRI현시소유실험동물재술후제3、6천균말견명현종류형성,제9천가견종류결절생장,량개실험조종류재제9、12천횡단위최대층면면적균대우대조조(F=4.21,P<0.05;F=8.52,P<0.01).면역조화결과 표명량개실험조종류VEGF표체균명현고우대조조(F=9.58,P<0.01),nm23기인단백표체균저우대조조(F=4.61,P<0.05),MSC혼합이식조PCNA표체고우대조조[d'(1,0.05)>=0.34,d'(1,0.01)>=0.63,P<0.05],MSC정맥이식조PCNA표체여대조조차이무통계학의의[d'(1,0.05)>=0.32,d'(1,0.01)>=0.48,P>0.05],2개실험조종류조망지수여대조조차이균무통계학의의(F=1.25,P>0.05).결론대서MSC이식능영향Walker-256간암VEGF、nm23이급PCNA적표체,유리우종류적생장.
Objective To evaluate the effects of mesenchymal stem cell (MSC) transplantation on the growth of liver cancer. Methods MSCs were isolated from the bone marrows of SD rats. Walker-256 cancer cells were isolated from the cancerous ascites of rat and cultured. Forty-five SD rats were randomly divided into 3 equal groups: mixed transplantation group undergoing laparotomy and transplantation of cancer cells mixed with MSCs into the liver, MSC Ⅳ transplantation group undergoing injection of MSCs into the caudal vein, and control group undergoing only MSC transplantation into the liver.MR imaging was performed s at days 3, 6, 9 and 12 after modeling to measure the maximum cross section area of the tumor. At day 12 the rats were killed after MR imaging with their livers taken out to undergo HE staining and pathological examination. Immunohisochenmisry was used to detect the expression of vascular endothelial cell growth factors (VEGF), nm23 gene, a tumor metastasis inhibiting gene, and proliferating cell nuclear antigen (PCNA), a nuclear polypeptide necessary in the DNA synthesis. Results No significant evidence of tumor formation was detected by MRI at days 3 and 6 after modeling in all rats and tumor nodules were observed since day 9. The maximum cross section areas of tumor of the mixed transplantation group and MSC Ⅳ transplantation group were significantly larger than that of the control group at days 9 and 12 ( F =4.21, P < 0. 05 ; F = 8. 52, P < 0. 01). Immunohistochemistry showed that VEGF expression levels of the two study groups were both significantly higher than that of the control group ( F = 9. 58,P < 0. 01 ), while the nm23 gene expression levels of the 2 study groups were both significantly lower than that of the control group (F =4.61 ,P <0.05 ). The FCNA expression level of the mixed transplantation group was significantly higher than that of the control group (d'(1,0.05) = 0.34, d'(1,0.01) = 0. 63, P < 0. 05 ), however, there was no significant difference in the PCNA expression level between the MSCs Ⅳ transplantation group and the control group (d'(1,0.05) =0. 32,d'(1,0.01) =0.48,P >0. 05). There was no significant difference in the tumor apoptotic index between the 2 study groups and the control group (F = 1.25, P > 0. 05 ). Conclusion MSC transplantation increases the expression of VEGF and PCNA, while decreases the expression of nm23 gene in cancer cells, thus favoring the tumor growth.